Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy. - Wikidata - wikimedia - TriplyDB

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.

http://www.wikidata.org/entity/Q47419398

about

Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practice The interferon beta therapies for treatment of relapsing-remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alon Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.Predictors of disability worsening in clinically isolated syndrome.Interferon-beta 1b in the treatment of multiple sclerosis.Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?Clinical effects and tolerability of high-dose, high-frequency recombinant interferon beta-1a in patients with multiple sclerosis: maximizing therapy through long-term adherence.Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence.Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.Changes in first-line injectable disease-modifying therapy for multiple sclerosis: predictors of non-adherence, switching, discontinuation, and interruption of drugs.Comparative effectiveness of interferons in relapsing-remitting multiple sclerosis: a meta-analysis of real-world studies.Immunomodulatory treatment of multiple sclerosis in denmark: a prospective nationwide survey.Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies.Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.Pharmacotherapy of multiple sclerosis: the PROOF trial.Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis.Response to interferon-beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria The inclusion of real world evidence in clinical development planning

P2860

Q26752859-DCC9C7CD-DCA0-4457-85BA-415049E9EB86 Q28743480-2134B3E0-F6CA-4FE3-BA34-48B6A095E0D8 Q35276609-0A8D531A-A04C-4D41-BC5B-1D6ABFDFC0CB Q35280670-79E06918-D1C0-415F-B6C2-3CCF2C833E09 Q35619185-AC3032A9-E179-4739-9772-80178FF5F911 Q36327113-718A2908-C4E2-4ED5-B2F4-320A3DC0574C Q36359388-5DA5B201-3E78-461A-AC51-0FDE4E8DA167 Q37706612-83795DCF-8D3C-4F0E-956B-FE79CA34D893 Q37976344-4B9A5B48-A564-4D57-ADBE-9292C9AE9456 Q38050313-617C4BD8-E3D8-47C3-86B7-B232F619DD5D Q39025672-3B2C28F0-9845-4655-BE05-3BFD9DE9BD2D Q39061969-E48002FF-4844-49FE-A552-E0489D7DBD8F Q42687809-0CF54B2B-0E87-4944-8871-71B8BD61D15D Q43609601-CA35FC3C-FC5A-4173-91CA-4251F0C96F76 Q47639943-5A68AEA1-1FC6-44E6-BADE-85FFCF3AEC25 Q47743703-B19A6A3F-B298-47BD-9CC3-3EBABC3141A3 Q50787818-DFDCC1B0-60D5-446D-B6B6-A202B83B4280 Q58452069-9745E6B8-B6B9-4664-A722-D59D19688A43 Q58694932-926C22C9-44E1-4E59-AEFD-81D18EA755A1

P2860

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.

http://www.wikidata.org/entity/Q47419398

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Interferon beta in relapsing-r ...... eting study in southern Italy.

@en

Interferon beta in relapsing-r ...... eting study in southern Italy.

@nl

type

label

Interferon beta in relapsing-r ...... eting study in southern Italy.

@en

Interferon beta in relapsing-r ...... eting study in southern Italy.

@nl

prefLabel

Interferon beta in relapsing-r ...... eting study in southern Italy.

@en

Interferon beta in relapsing-r ...... eting study in southern Italy.

@nl

P1433

Q47419398-5C6E5A7A-F02E-4BD6-9432-AD75DF403ED9

P1476

Q47419398-F21ED0CE-449F-4268-8DC3-3D64AC18671F

P2093

Q47419398-0A988EB9-A665-404C-A542-91454B282695

Q47419398-331B9873-D155-4630-B9F6-3B5DECC7E194

Q47419398-6AC7C360-3CB2-4994-8AF1-468DB99D103E

Q47419398-C06575D0-1315-4690-B3B3-E62083348C1E

Q47419398-F416C9B1-40EF-4CAD-BD4C-83D1B0D47537

Q47419398-F8B46283-5C3D-42A5-ACB1-A1CD2753A799

Q47419398-FAB82501-6AF6-40C9-9C07-13956A753A36

P2860

Q47419398-5A167F30-69F0-40D6-98D5-0B98AAF88565

Q47419398-69535317-0F9B-46DA-8835-4B6B779D486A

Q47419398-7215FF06-6890-4F4A-8B8A-22CCDD36A57C

Q47419398-9A7C7723-7487-4C0E-9472-2C57AFFE21DF

Q47419398-BDCF33FA-2332-4B6E-A72A-6031BD8FF4FE

Q47419398-E7DA8AA3-806E-4A7C-A2C2-502D771A013E

Q47419398-E98996E9-9EB4-4214-8472-E206DF345F38

Q47419398-F7295916-BA47-4831-8811-4F810C210442

Q47419398-FE0385A5-A2E5-4AFB-BB42-F805954CD75F

P304

Q47419398-265F769F-A10C-4C5C-BB0F-DDE67F023691

P31

Q47419398-A31FB90B-4E73-4357-B4B0-BF1F3231A339

P356

Q47419398-31F18FD4-16F2-45F8-BCDB-AEF37FEDE52C

P433

Q47419398-FA91CFF5-390D-4C96-A422-2D6934E6B44B

P478

Q47419398-DE188CB9-3B64-43B7-827F-74552CD4BC07

P50

Q47419398-74C3C910-D498-4BD0-B946-631F14116236

Q47419398-EA88B9AA-1BF4-4C32-A942-89783CDF5F2E

Q47419398-EA97BC49-0522-4AF3-9CB5-679020F7B4B7

P577

Q47419398-DD2691CB-8C15-4664-9B39-A2E1F698E4F8

P698

Q47419398-D0BDB919-A06F-44DF-8DEB-FF9C012BC5D8

P921

Q47419398-6658F232-487B-4826-8634-239F16FCC5F8

Q47419398-7DB98F9A-1BE2-466A-8D9B-8069D439D818

Q47419398-BFB61071-29AA-4941-AD0C-4A17A36E7322

P356

1352458503MS948OA

P1433

Multiple Sclerosis Journal

P1476

Interferon beta in relapsing-r ...... eting study in southern Italy.

@en

P2093

Aurora Fuiani

http://www.w3.org/2001/XMLSchema#string

Carlo Avolio

http://www.w3.org/2001/XMLSchema#string

Damiano Paolicelli

http://www.w3.org/2001/XMLSchema#string

Fabrizio Giuliani

http://www.w3.org/2001/XMLSchema#string

Francesca De Robertis

http://www.w3.org/2001/XMLSchema#string

Giovanni Bosco Zimatore

http://www.w3.org/2001/XMLSchema#string

Southern Italy MS Group

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Randomized, controlled trials, observational studies, and the hierarchy of research designs

A comparison of observational studies and randomized, controlled trials.

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Interferons in relapsing remitting multiple sclerosis: a systematic review.

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory.

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

P304

451-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/1352458503MS948OA

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14582768

http://www.w3.org/2001/XMLSchema#string

P921

relapsing-remitting multiple sclerosis

multiple sclerosis